Taiwan FDA registration 0f0edd35d5ef61086c6f88e84544b441
"Reuters Nice" Reuters Nice 018 percutaneous puncture angioplasty drug-coated balloon catheter
TW: “路透尼斯” 路透尼斯018經皮穿刺血管成形術藥物塗層球囊導管
Taiwan·Risk Class 2·Lutonix, Inc.; C.R. BARD, INC.·Registered May 08, 2022 – May 08, 2027ActiveRegistration details
- Analysis ID
- 0f0edd35d5ef61086c6f88e84544b441
- Customs Code
- DHA05603542706
Company information
- Manufacturer
- Lutonix, Inc.; C.R. BARD, INC.
- Manufacturer Country
- United States
- Authorized Representative
- BARD PACIFIC HEALTH CARE CO., LTD.
Product details
- Intended Use
- Details are as detailed as approved Chinese instructions
- Product Type (Level 1)
- E Cardiovascular Medicine Science
- Product Type (Level 2)
- E.1250 Percutaneous catheters
- Import Information
- import
Dates and status
- Registration Date
- May 08, 2022
- Expiry Date
- May 08, 2027
About this record
Access comprehensive regulatory information for "Reuters Nice" Reuters Nice 018 percutaneous puncture angioplasty drug-coated balloon catheter in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 0f0edd35d5ef61086c6f88e84544b441 and manufactured by Lutonix, Inc.; C.R. BARD, INC.. The authorized representative in Taiwan is BARD PACIFIC HEALTH CARE CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices